![Jane Chung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jane Chung
Vorstandsvorsitzender bei
SUTRO BIOPHARMA, INC.
Vermögen: 714 962 $ am 30.06.2026
Profil
Jane Chung is President, Chief Executive Officer, COO & Director at Sutro Biopharma, Inc. since 2025.
Former roles include Independent Director at Viracta Therapeutics, Inc. from 2022 to 2024, President & General Manager at AstraZeneca Canada, Inc. from 2015 to 2021, Director-Sales Productivity & Effectiveness at Onyx Pharmaceuticals, Inc. from 2013 to 2015, and Senior Manager-Marketing at Genentech, Inc. from 2003 to 2013.
Education includes undergraduate studies at The Trustees of Columbia University in The City of New York and St. John's University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 21’535 ( 0.13% ) | 714 962 $ | 30.06.2026 |
Aktive Positionen von Jane Chung
| Unternehmen | Position | Beginn |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Vorstandsvorsitzender | 13.03.2025 |
Ehemalige bekannte Positionen von Jane Chung
| Unternehmen | Position | Ende |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.10.2024 |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Präsident | 01.08.2021 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01.01.2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Vertrieb & Marketing | 01.01.2013 |
Ausbildung von Jane Chung
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
